CTMX
CytomX Therapeutics Inc

4,466
Mkt Cap
$901.4M
Volume
3.67M
52W High
$6.35
52W Low
$0.40
PE Ratio
12.72
CTMX Fundamentals
Price
$5.32
Prev Close
$5.43
Open
$5.45
50D MA
$4.73
Beta
1.42
Avg. Volume
3.34M
EPS (Annual)
$0.3761
P/B
8.18
Rev/Employee
$1.14M
$3.95
Loading...
Loading...
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
121

Frequently Asked Questions

What is Market Cap of CytomX Therapeutics Inc?
What is the 52-week high for CytomX Therapeutics Inc?
What is the 52-week low for CytomX Therapeutics Inc?
What is CytomX Therapeutics Inc stock price today?
What was CytomX Therapeutics Inc stock price yesterday?
What is the PE ratio of CytomX Therapeutics Inc?
What is the Price-to-Book ratio of CytomX Therapeutics Inc?
What is the 50-day moving average of CytomX Therapeutics Inc?
How many employees does CytomX Therapeutics Inc have?

Latest CTMX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.